ASSEMBLY BIOSCIENCES, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Assembly Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Assembly Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$12.2M, a 30.2% increase year-over-year.
  • Assembly Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$50.5M, a 39.4% increase year-over-year.
  • Assembly Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$64.6M, a 31.3% increase from 2022.
  • Assembly Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$94.1M, a 29.1% increase from 2021.
  • Assembly Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$133M, a 105% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$50.5M -$12.2M +$5.29M +30.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$55.8M -$10.7M +$8.83M +45.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$64.6M -$12.6M +$10.4M +45.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$75.1M -$15M +$8.35M +35.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$83.4M -$17.5M +$7.09M +28.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$90.5M -$19.6M +$3.6M +15.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$94.1M -$23M +$39.9M +63.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$134M -$23.4M -$4.53M -24% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$129M -$24.6M -$907K -3.83% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$129M -$23.2M +$4.1M +15% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$133M -$62.9M -$23.2M -58.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$109M -$18.9M -$14.9M -370% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$94.6M -$23.7M -$30.2M -460% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$64.3M -$27.3M +$436K +1.57% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$64.8M -$39.6M -$11M -38.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$53.8M -$4.02M +$22M +84.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$75.8M $6.58M +$26.3M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$102M -$27.7M +$642K +2.27% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$103M -$28.7M -$2.36M -8.97% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$100M -$26M -$3.42M -15.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$96.9M -$19.7M +$7.47M +27.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$104M -$28.3M -$11.7M -70% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$92.7M -$26.3M -$14M -114% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$78.7M -$22.6M -$10.1M -81.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$68.6M -$27.2M -$13.6M -100% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 -$55M -$16.7M -$2.74M -19.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$52.2M -$12.3M -$412K -3.47% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-04
Q3 2017 -$51.8M -$12.5M -$771K -6.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$51M -$13.6M -$3.11M -29.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$47.9M -$13.9M -$2.65M -23.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 -$45.3M -$11.9M -$3.69M -45.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$41.6M -$11.7M -$4.56M -64% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 -$37M -$10.5M -$3.3M -46.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$33.7M -$11.3M -$4.07M -56.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$29.7M -$8.18M -$1.89M -30.1% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 -$27.8M -$7.12M +$3.93M +35.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$31.7M -$7.15M -$4.65M -185% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$27M -$7.2M -$3.09M -75.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$24M -$6.28M -$191K -3.13% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-02
Q3 2014 -$23.8M -$11.1M -$6.12M -124% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$17.6M -$2.51M +$2.3M +47.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$19.9M -$4.11M -$341K -9.05% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$19.6M -$6.09M -$2.28M -59.7% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-03-16
Q3 2013 -$17.3M -$4.93M +$437K +8.14% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-17
Q2 2013 -$17.8M -$4.81M +$2.67M +35.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$20.4M -$3.77M +$4.42M +54% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$24.9M -$3.82M +$15.1M +79.8% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$39.9M -$5.37M +$176K +3.17% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$40.1M -$7.48M -$577K -8.36% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$39.5M -$8.19M -$5.52M -207% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$34M -$18.9M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 -$5.55M -$5.04M -987% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$6.9M -$6.24M -946% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$2.67M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$510K Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-11-18
Q2 2010 -$660K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.